Nanocarriers for the Delivery of Combination Drugs focuses on the role of nanocarriers in the delivery of combination drugs for the management and treatment of various diseases. Nanocarriers belonging to the category of polymeric nanoparticles, dendrimers, lipidic nanocarriers (like nanoemulsions), liposomes, solid lipid nanoparticles, nanostructured lipid carriers are now being used in the drug delivery of combination drugs. This book helps readers assimilate all the information available surrounding the application of various nanocarrier technologies for the delivery of combination drugs of synthetic and natural origin, including small and large molecules.
This is an important reference source for pharmaceutical scientists and biomaterials scientists who are looking to gain an increased understanding on how nanotechnology is improving the efficiency of combination drug delivery.
1. Nanocarriers for the Delivery of Combination Drugs - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page ii 4. Table of Contents - p. Page iii 5. Copyright - p. Page iv 6. Dedication - p. Page v 7. Contributors - p. Page v 8. Editor Biographies - p. Page ix 9. Preface - p. Page xi 10. List of Illustrations - p. Page xiv 11. List of Tables - p. Page xv 12. Chapter 1 : Combination therapy: past, present, and future - p. Page xv 13. Chapter 2 : Liposomal nanocarriers for delivery of combination drugs - p. Page 37 14. Chapter 3 : Polymeric nanocarriers for delivery of combination drugs - p. Page 77 15. Chapter 4 : Mesoporous silica nanoparticles for drug combination delivery in cancer therapy: background, current insights, and future perspectives - p. Page 109 16. Chapter 5 : Therapeutic implications of inorganic nanoparticles for codelivery of bioactives in cancer therapy - p. Page 148 17. Chapter 6 : Emerging role of inorganic and metal nanoparticles for the delivery of combination of drugs in wound healing and tissue regeneration - p. Page 188 18. Chapter 7 : Carbon-based nanoparticles and dendrimers for delivery of combination drugs - p. Page 219 19. Chapter 8 : Lipid-based combinational drug delivery systems: Maximizing the performance of cocktail therapy - p. Page 252 20. Chapter 9 : RNAi-based combination therapies - p. Page 296 21. Chapter 10 : Synergistic combination of phytotherapeutics for infectious diseases - p. Page 328 22. Chapter 11 : Combination drug delivery using cold atmospheric plasma technology - p. Page 380 23. Chapter 12 : Nanocarriers for theranostic applications - p. Page 414 24. Chapter 13 : FDC in nanotechnology: regulatory landscape - p. Page 460 25. Index - p. Page 493
Nanocarriers for the Delivery of Combination Drugs focuses on the role of nanocarriers in the delivery of combination drugs for the management and treatment of various diseases. Nanocarriers belonging to the category of polymeric nanoparticles, dendrimers, lipidic nanocarriers (like nanoemulsions), liposomes, solid lipid nanoparticles, nanostructured lipid carriers are now being used in the drug delivery of combination drugs. This book helps readers assimilate all the information available surrounding the application of various nanocarrier technologies for the delivery of combination drugs of synthetic and natural origin, including small and large molecules.
This is an important reference source for pharmaceutical scientists and biomaterials scientists who are looking to gain an increased understanding on how nanotechnology is improving the efficiency of combination drug delivery.
1. Nanocarriers for the Delivery of Combination Drugs - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page ii 4. Table of Contents - p. Page iii 5. Copyright - p. Page iv 6. Dedication - p. Page v 7. Contributors - p. Page v 8. Editor Biographies - p. Page ix 9. Preface - p. Page xi 10. List of Illustrations - p. Page xiv 11. List of Tables - p. Page xv 12. Chapter 1 : Combination therapy: past, present, and future - p. Page xv 13. Chapter 2 : Liposomal nanocarriers for delivery of combination drugs - p. Page 37 14. Chapter 3 : Polymeric nanocarriers for delivery of combination drugs - p. Page 77 15. Chapter 4 : Mesoporous silica nanoparticles for drug combination delivery in cancer therapy: background, current insights, and future perspectives - p. Page 109 16. Chapter 5 : Therapeutic implications of inorganic nanoparticles for codelivery of bioactives in cancer therapy - p. Page 148 17. Chapter 6 : Emerging role of inorganic and metal nanoparticles for the delivery of combination of drugs in wound healing and tissue regeneration - p. Page 188 18. Chapter 7 : Carbon-based nanoparticles and dendrimers for delivery of combination drugs - p. Page 219 19. Chapter 8 : Lipid-based combinational drug delivery systems: Maximizing the performance of cocktail therapy - p. Page 252 20. Chapter 9 : RNAi-based combination therapies - p. Page 296 21. Chapter 10 : Synergistic combination of phytotherapeutics for infectious diseases - p. Page 328 22. Chapter 11 : Combination drug delivery using cold atmospheric plasma technology - p. Page 380 23. Chapter 12 : Nanocarriers for theranostic applications - p. Page 414 24. Chapter 13 : FDC in nanotechnology: regulatory landscape - p. Page 460 25. Index - p. Page 493
